An Open Effort Mindset
The "open effort" research funding model emphasizes on collaboration and transparency in the fight against Duchenne Muscular Dystrophy (DMD). By making research findings accessible to pharmaceutical and research organizations, this model fosters a collaborative environment where multiple entities can work together to refine and enhance the treatment approach.
The open sharing of data and discoveries accelerates the pace of innovation, allowing for more rapid advancements in therapies and potentially leading to breakthroughs that could make DMD a condition of the past. This inclusive strategy not only maximizes resource utilization but also encourages diverse perspectives and expertise, ultimately benefiting patients by expediting the development of effective treatments.
Current Research Study in Pipeline
Click Here: ∆6-25 Mice Model Creation Fundraising Campaign: Goal $25k
| Targeted Start Date | January, 3rd 2025 |
| Estimated Timeline of ∆6-25 Mice Model Creation | March, 31st 2025 |
| Number of Patients Exons 6 & 7 Skipping May Benefit | 180 Patients |
| ∆6-25 Mice Model Cost (Campaign's Goal) | $25,000 |
Next Research Study in Pipeline
Click Here: ∆7-44 lncRNA Study Fundraising Campaign: Goal $86k
| Targeted Start Date | March , 01st 2025 |
| Estimated Completion Date | March, 01st 2026 |
| Number of Patients Benefitting | All In-Frame Deletions |
| ∆6-25 Mice Model Cost (Campaign's Goal) | $86,000 |